According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...

CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a natural defense system in bacteria that scientists have adapted into a powerful gene-editing tool. This ...

Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Virginia Tech scientists found that age-related memory loss stems from molecular changes in the brain. Memory decline might not be just a natural part of aging. Researchers at Virginia Tech have ...

Nantucket High School and the Egan Maritime Institute will bring island students to the Marine Biological Laboratory in Woods ...

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

Research from UChicago dissects how a single genetic switch helps butterflies mimic wing patterns of other species to protect ...

mRNA is also being used in tandem with the gene-editing system CRISPR to revolutionize treatments for genetic disease.

Vinay Prasad told Bloomberg that the FDA is going to be “extremely flexible” regarding gene editing therapies.

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...